Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
Aiswarya Chaudhuri, Dulla Naveen Kumar, Rasheed A. Shaik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10068-10068
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
Xiangyi Kong, Yihang Qi, Xiangyu Wang, et al.
Progress in Materials Science (2023) Vol. 134, pp. 101070-101070
Closed Access | Times Cited: 76
Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy
Ana Camila Marques, Paulo Costa, Sérgia Velho, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 216-216
Open Access | Times Cited: 40
Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review
Sonia Fathi‐karkan, Rabia Arshad, Abbas Rahdar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115676-115676
Closed Access | Times Cited: 37
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 14
Polymeric micelles: A novel drug delivery system for the treatment of breast cancer
Aiswarya Chaudhuri, Korra Ramesh, Dulla Naveen Kumar, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 77, pp. 103886-103886
Closed Access | Times Cited: 47
Nano‐biotechnology in tumour and cancerous disease: A perspective review
Ambikesh Soni, Manohar Prasad Bhandari, Gagan Kant Tripathi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 6, pp. 737-762
Open Access | Times Cited: 32
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong-Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 28
A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters
Afshana Quadiri, Swayam Prakash, Latifa Zayou, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 47-47
Open Access
Nanotechnology for cancer immunotherapy
Xiaoqi Zheng, Bella B. Manshian, Stefaan J. Soenen
Elsevier eBooks (2025)
Closed Access
Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
Rajesh Pradhan, Anuradha Dey, Rajeev Taliyan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 246-246
Open Access | Times Cited: 19
Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment
Sofia Quintas, Ana Manuela Canha Borges, Maria José Oliveira, et al.
Small (2023)
Open Access | Times Cited: 19
Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis
Moataz B. Zewail, Sanaa A. El‐Gizawy, Gihan F. Asaad, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123224-123224
Closed Access | Times Cited: 19
Impact of the Drug Loading Method on the Drug Distribution and Biological Efficacy of Exosomes
Dulla Naveen Kumar, Aiswarya Chaudhuri, Dinesh Kumar, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 6
Closed Access | Times Cited: 16
Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations
Stefania Scialla, Mahmoud S. Hanafy, Jieliang Wang, et al.
International Journal of Pharmaceutics (2023) Vol. 632, pp. 122575-122575
Open Access | Times Cited: 14
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
Maria Daniela Ferreira, Joana Duarte, Francisco Veiga, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 678-678
Open Access | Times Cited: 14
Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy
Kyumin Mo, Ayoung Kim, Soohyun Choe, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2065-2065
Open Access | Times Cited: 14
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2661-2661
Open Access | Times Cited: 13
Scope of Nanomaterials in Treating Neurological Disorders
Aaryan Gupta, Arpita Roy, Kirtanjot Kaur, et al.
OBM Neurobiology (2024) Vol. 08, Iss. 01, pp. 1-22
Open Access | Times Cited: 3
Recent advanced lipid-based nanomedicines for overcoming cancer resistance
Piroonrat Dechbumroong, Runjing Hu, Wisawat Keaswejjareansuk, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Unique therapeutic potentialities of exosomes based nanodrug carriers to target tumor microenvironment in cancer therapy
Safir Ullah Khan, Munir Ullah Khan, Y. Gao, et al.
OpenNano (2022) Vol. 8, pp. 100091-100091
Open Access | Times Cited: 17
Facile fabrication of TPGS-PCL polymeric nanoparticles for paclitaxel delivery to breast cancer: investigation of antiproliferation and apoptosis induction
Tong Chen, Fei Xing, Yu Sun
Journal of Experimental Nanoscience (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Decreased Lung Metastasis in Triple Negative Breast Cancer Following Locally Delivered Supratherapeutic Paclitaxel-Loaded Polyglycerol Carbonate Nanoparticle Therapy
Robert C. Sabatelle, Ngoc-Quynh Chu, William A. Blessing, et al.
Biomacromolecules (2024) Vol. 25, Iss. 3, pp. 1800-1809
Closed Access | Times Cited: 2
Advancements and prospects of lipid-based nanoparticles: dual frontiers in cancer treatment and vaccine development
Ibrahim Shaw, George Frimpong Boafo, Yimer Seid Ali, et al.
Journal of Microencapsulation (2024) Vol. 41, Iss. 3, pp. 226-254
Closed Access | Times Cited: 2
Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials
Rama Rao Malla, Mundla Srilatha, Veda Muppala, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 707-720
Closed Access | Times Cited: 2
Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer
Yirivinti Hayagreeva Dinakar, Naveen Rajana, Nalla Usha Kumari, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 8
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top